Skip to content

Role of ChatGPT in Vestibular Schwannoma Management

Role of ChatGPT in Vestibular Schwannoma Management

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06163664
Enrollment
0
Registered
2023-12-11
Start date
2027-01-01
Completion date
2027-11-30
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Schwannoma

Brief summary

Previous studies have demonstrated that patients frequently undergo significant decision conflict regarding major medical decisions in otolaryngology. There lack validated tools available for decision support for patients. While limited evidence has demonstrated that clinical decision support tools can alleviate decision conflict for patients with diagnosis in otolaryngology, conversational language models were not employed in these studies and may provide additional benefit in this context. This study seeks to evaluate the efficacy of using ChatGPT, a conversational language model with basic clinical knowledge, in alleviating decision conflict for patients with new diagnosis in otolaryngology. For this pilot study, vestibular schwannoma, a benign tumor that develops on the vestibular nerve with known clinical equipoise, has been chosen for the initial study diagnosis. Efficacy will be evaluated by comparison of responses to the Decisional Conflict Scale (DCS) and Satisfaction with Decision (SWD) scores between a group given training in ChatGPT and a control group (no ChatGPT training).

Interventions

BEHAVIORALUse of chatGPT for 1 week

Use of chatGPT for 1 week

Sponsors

University of Southern California
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * Diagnosed with vestibular schwannoma * Have access to internet-enabled device that is compatible with ChatGPT

Exclusion criteria

* \< 18 years old * patient without diagnosis of vestibular schwannoma * patient does not have access to internet-enabled device * patient who declines study participation

Design outcomes

Primary

MeasureTime frameDescription
Changes in scores of Decisional Conflict Scale after ChatGPT usebaseline, 1 week follow up, 2 week follow upThe Decisional Conflict Scale (DCS) measures 5 dimensions of decision making (feeling: uncertain, uninformed, unclear about values, unsupported; ineffective decision making). 15-item validated questionnaire. Score range 5-75 (higher score corresponding to higher levels of conflict in decision making)
Changes in scores of Satisfaction with Decision after ChatGPT usebaseline, 1 week follow up, 2 week follow upThe Satisfaction with Decision (SWD) scale measures satisfaction with health care decisions. 6-item validated questionnaire. Score range 5-30 (higher score corresponding to higher levels of satisfaction with decision)
Changes in scores for Knowledge on vestibular schwannoma management after ChatGPT usebaseline, 1 week follow up, 2 week follow up4-item questionnaire (Likert scale) assessing participants' confidence in understanding the diagnosis and treatment options for vestibular schwannoma. Score range 5-20 (higher score corresponding to higher levels of confidence in understanding diagnosis and management of vestibular schwannoma)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026